Glaukos Corp

Official name: 
Glaukos Corporation

Corporate Profile

Registration country: 
United States
Industry: 
Biotechnology
Overview 
Glaukos Corp is committed to transforming glaucoma therapy. To this end, Glaukos is bypassing anatomical impediments and treatment conventions to develop treatments that restore natural physiologic outflow as a foundation of significant, steady and sustained glaucoma management. Today, they are at the beginning with an innovative micro technology. In collaboration with their clinician partners, they are building technology towards a safer and more effective treatment for preserving vision in patients with primary open-angle glaucoma.

Investors

Investor Profile Amount Stage Date
Domain Associates LLC Series D 29th Aug 2008
Frazier Healthcare Ventures Series D 29th Aug 2008
InterWest Partners Series D 29th Aug 2008
MeriTech Capital Partners
Montreux Equity Partners Series D 29th Aug 2008
OrbiMed Advisors LLC Series D 29th Aug 2008
OrbiMed Advisors LLC
Versant Ventures Series D 29th Aug 2008

Current employees

No current employees available

add an employee

RECORD ID: 288744